Blood Gas Analyzers Market Size, Share, Growth, and Industry Analysis, By Type (Portable and Bench-top), By Downstream Industry (Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers and Educational Institutes), and Regional Forecast to 2033

BLOOD GAS ANALYZERS MARKET OVERVIEW

Blood Gas Analyzers Market Size was estimated at USD 908.28 million in 2024 and it is expected to grow from USD 954.52 million in 2025 to USD 1054.15 million by 2033. The Market CAGR (growth rate) is expected to be around 5.09% during the forecast period (2025 - 2033).

The blood gas analyzers market is oriented on devices, which are used to analyze blood gases such as O₂, CO₂ and pH in the patients’ blood samples. These devices are quite vital in handling patients with respiratory, metabolic, as well as electrolyte disorders mainly in critical care, emergency as well as surgical patients. Fuelled by increasing incidence of chronic diseases such as asthma, COPD, diabetes and growing need for point of care testing the market has shown steady growth. The constant increase in new technologies for example portable analyzer and automated systems is also giving a boost to the use of these devices and making it easier to use. North America, Europe and Asia-Pacific are major markets; factors such as increase in the healthcare costs and betterment of the Health care facilities drive this growth. However, one drawback arising from the increased use of analyzers is that they are relatively expensive and may hence slow development in some of the emerging economies.

• • 

    Request a Free sample to learn more about this report.

BLOOD GAS ANALYZERS MARKET KEY FINDINGS

• Market Size and Growth: The Blood Gas Analyzers Market size was USD 908.28 Million in 2024, is projected to grow to USD 943.55 Million by 2025 and exceed USD 1054.15 Million by 2033, with a CAGR of 5.09%.

• Key Market Driver: Rising ICU admissions and emergency diagnostics are pushing demand—ICU beds worldwide jumped to 13 million+ post-pandemic, driving the need for quicker and more reliable blood gas monitoring.

• Major Market Restraint: High cost of maintenance and calibration hurts adoption—some advanced benchtop analyzers cost $15,000–$20,000 upfront, with annual maintenance running over $1,000.

• Emerging Trends: Portable point-of-care analyzers are changing the game—by 2023, over 40% of U.S. hospitals adopted handheld devices for bedside arterial blood tests. Also, integration with EMRs is picking up pace.

• Regional Leadership: North America leads the pack, with the U.S. accounting for nearly 35% of global demand, thanks to its strong critical care infrastructure and early tech adoption.

• Competitive Landscape: Around 10–12 companies dominate the landscape, including Siemens Healthineers, Radiometer, and Roche. The top three players alone hold nearly 60% of market share.

• Market Segmentation: The demand from hospitals is highest, making up roughly 45% of global usage, followed closely by clinics and diagnostic labs in urban centers.

• Recent Development: In 2023, Abbott launched its new i-STAT Alinity platform—a next-gen point-of-care analyzer capable of testing blood gases, electrolytes, and hematology within just 2 minutes of collection.

GLOBAL CRISES IMPACTING BLOOD GAS ANALYZERS MARKET - COVID-19 IMPACT

"Blood Gas Analyzers market had a negative effect due to disruption in supply chain during COVID-19 pandemic"

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The COVID-19 outbreak has helped in advancing Blood Gas Analyzers market share, predominantly concerning the huge stress that healthcare systems across the world have received. Hospitals and laboratories were under pressure to deliver the availability of critical care and respiratory support, which caused a short-term duration of blood gas analyzers and their accessories. Elective surgeries were received and postponed leading to reduced sales and installation of these devices across different health care facilities. Moreover, the major issues in supply chain and manufacturing delay and its impact on blood gas analyzers delivery have been the some of the major aspects that have checked the growth of this market. This was driven further by the effects of a recession and resulting budget constraints, which forced healthcare facilities to identify critical investments in healthcare technology, such as advanced blood gas analyzers. Although supply chain disruptions were mitigated as demand returned to normal due to healthcare organisations reinventing demand, the advent of COVID-19 affected the market purchasing behaviour and temporarily stagnated adoption of newer technologies during the crisis.

LATEST TREND

"Growing Adoption of Point-of-Care Blood Gas Analyzers to Drive Market Growth"

One latest trend in the blood gas analyzers market is the use of Point-of-Care (POC) testing devices is becoming popular. These point-of-care systems can quickly and accurately perform blood gas analysis at the point of care, such as at the patient’s bedside or in ambulatory care, thus greatly improving the management of a patient. Basically, the reallocation of extensive POC testing stems from the desire to make decisions that are relevant in life threatening situations and other crucial and emergent facilities such as ICU. Current models of POC blood gas analyzers are developing to be smarter and they incorporate features of checking multiple parameters at a go, compatibility with electronic health records and the touch-screen interfaces. This line of thought is paralleled by a gradual decentralisation of healthcare delivery, coupled with the COVID-19 pandemic that has highlighted the need to decentralise, efficient testing that would otherwise overcrowd the laboratories again..

BLOOD GAS ANALYZERS MARKET SEGMENTATION

By Type

Based on Type, the global market can be categorized into Portable and Bench-top.

• Portable: These portable units are intended for point-of-care use so that various blood gas values can be obtained by a clinician at the patient’s side or in critical care circumstances. Its portability improves the patient care delivery through quick test results, speedy decision-making process of critical environments.

• Bench-top: These are larger and usually are intended for use in laboratories because they can provide a list of tests and have a higher throughput than the others. They are active for the regular use and can provide an accurate result for many samples at the same time that make them perfect for hospitals or clinical labs.

By Application

Based on Industry Analysis, the global market can be categorized into Hospitals, Clinics, Diagnostic Centers, Ambulatory Surgical Centers and Educational Institutes.

• Hospitals: Blood gas analysers are frequently being used in hospital laboratories most especially in the critical and emergency care to determine the respiratory and metabolic status of human patients. They are fast; this is something valuable for the acute care situations since the prompt action frequently defines the further state of the patient.

• Clinics:  In outpatient facilities, blood gas analyzers are critical in providing informative parameters to treating chronic respiratory and metabolic disorders. These forms assist to deliver quick assessment since many people trust private hospitals than big ones and this in turn boosts patient satisfaction since many rarely have to be referred to another larger hospital.

• Diagnostic Centers: Blood gas analyzers play a crucial role in diagnostic centers for testing and achieving maximum target in diagnosing and treating diseases by physicians Pan& Yu, 2014. These centres may well centre their services around specialized testing, which involves the analyzers being central to the services delivery.

• Ambulatory Surgical Centers: In ambulatory surgical centers blood gas analyzers assist in evaluating the patient’s blood chemistry and gas status during and after surgery as well as during recovery. This makes them highly useful in almost all types of surgeries upon consideration of their portability.

• Educational Institutes: Blood gas analyzers are put to use within educational institutes where the learners as well as the faculty gain practical knowledge of precedence diagnosis procedures. OAHQ recognizes that these facilities advance the knowledge in clinical practice and technology in the healthcare field.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

"Contributing Factors of Chronic Diseases to Boost the Market"

A factor in the Blood Gas Analyzers market growth is the rising incidence of chronic diseases like respiratory diseases (COPD, asthma, etc.) and metabolic disorders (diabetes). These conditions frequently necessitate frequent measurement of blood gases in order to monitor the effectiveness of treatment. And since the people’s average age is increasing, as well as the rate of chronic diseases that people get because of their lifestyle, the need for proper and prompt diagnostics has become even higher. These diseases are effectively managed through blood gas analyzers since they give real-time results; allow better patient care and treatment.

"Technological Advancements to Expand the Market"

The other factor that is putting pressure towards growth in the blood gas analyzers market is technological innovations. All the three hypotheses are present in the case of these innovations since they have led to portable and easily usable devices. They allow for point of care testing that implies testing at the patient bedside or outpatient department. Also, the advance of accuracy, multiple-flexing, and compatibility with the electronic health record system increases the overall productivity to monitor patients better. It is anticipated that healthcare providers will look for better and more effective diagnostic solutions to investigate this market growth as blood gas analyzer technology advances.

Restraining Factor

"High costs of blood gas analyzers Impede Market Growth"

High capital costs associated with sophisticated analyzers are also considered to be a major limiting factor of the blood gas analyzers market. In many healthcare organizations especially those within the developing world, there will be serious constraints within their financial plans through which they can be able to make the necessary investments in tees important diagnostic equipment. The cost that comprises the acquisition of said devices and the regular maintenance can act as a discouragement towards the expansion or even improvement of blood gas testing in most hospitals and clinics. This limitation can leading to reduced availability of timely diagnostic services thereby restraining market growth in sensitive price areas..

Opportunity

"Growth of Home Healthcare to Create Opportunity for the Product in the Market"

An emerging trend observed in the blood gas analyzers market is the trend of home health care aspirant. Due to the shifting of focus toward the patient, there are more and more calls for carrying out tests in home setting. This shift Is easily applicable to patients with chronic disorders that call for frequent measurement of blood gases. That is why portable blood gas analyzers designed specifically for home use present new opportunities and help to increase revenues. With decentralized care models continually being adopted especially by the health care systems globally, at home blood gas testing opportunity is set to grow significantly.

Challenge

"Legal Requirements and Codes Could Be a Potential Challenge for Consumers"

The industry faces a major challenge in the form of regulatory and quality requirements set by health authorities. Truly, regulatory approval of manufacturers’ devices may take long time and cost effectiveness bearing in mind that there are several legal procedures to be followed before a specific device can be produced. Furthermore, the requirement for accuracy, reliability and safety in experimentations may add further difficulty in creating them. Manufacturers’ obligation to accommodate the emerging and shifting requirements might prolong time to market and new product development, as well as raise overall costs, thus affecting market factors.

• • 

    Request a Free sampleto learn more about this report.

•  

BLOOD GAS ANALYZERS MARKET REGIONAL INSIGHTS

North America

The major market is the North American especially U.S. Blood Gas Analyzers market due to its greater per capita healthcare expenditure, superior level of healthcare facilities and increased focus on technology. It is proposed that key market participants and research and development activities in the region are responsible for the introduction of innovative blood gas analyzers. Also, the incidence of chronic diseases is on the rise due to the Development and advancements in technology creating a need to do analysis away from the centralized laboratory increases the growth of the market. Policies such as reimbursement policies and regulatory support helps healthcare providers to invest in advanced diagnostic technologies putting North America in a vantage point on the global blood gas analyzers market.

Europe

Europe is the leading market for blood gas analyzers since the continent has highly developed healthcare industry and patients’ management level. The increase in the use of technology in diagnostic services is the reason why the regional market will continue to grow. The use of advanced blood gas analyzers is most developed in Germany, France, and the UK because of the growing incidence of chronic diseases coupled with the need for effective testing solutions. Furthermore, encouraging government policies and policies towards development of fiscally health care system increase the market growth. The factors like focus on PCR and better health quality of patients boost Europe’s position in the blood gas analyzers market.

Asia

Asia is coming out as one of the most proliferating markets for blood gas analyzers due to the rising healthcare spending, rising asymptomatic demographic populace and extended healthcare solutions. Currently the developing countries like china and India are experiencing improvements in the establishment of enhanced health facilities and diagnostic equipments. Accurate results within few minutes of blood sample collection are essential for the diagnosis and treatment of these conditions in the growing healthcare systems of these nations, making blood gas analyzers crucial additions in hospitals and clinics. In addition, the increased adoption of the point of care testing and the increasing focus towards the significance of screening for the blood gases are contributing to the growth of the market in Asia and is identified as the growth region for the market.

KEY INDUSTRY PLAYERS

"Key Industry Players Shaping the Market through Innovation and Market Expansion"

Key industry players inside the blood gas analyzers market consist of Abbott Laboratories operating in point of care and laboratory testing segment, Roche Diagnostics for creating laboratory and point of care blood gas analyzers and Siemens Healthineers provides diagnostic imaging technologies. Another notable one is Thermo Fisher Scientific through which they supply all manner of laboratory products and consumables for its customers. Furthermore, both Medtronic and Philips are also market players that concentrate on improving the patient care throughout the innovative blood gas analysis systems. Such companies are prospective agents of technological changes and market expansion initiatives that create competition and innovations.

List of Market Players Profiled

• Abbott Laboratories (U.S.)
• Edan Instruments (China)
• Siemens Helathcare (Germany)
• Perlong Medical (China)

KEY INDUSTRY DEVELOPMENT

In August 2023: Siemens Healthineers revealed that it has recently released the Siemens RAPID Point 500e blood gas analyzer for point of care testing productivity and performance. This is an improved model with advanced touch screen, enhanced connection capability and compact real estate for performing comprehensive blood gases as well as other critical measurements promptly and accurately. The development of this analyzer is intended to establish a demand for real-time diagnosis in several facilities involving emergency and critical conditions

REPORT COVERAGE

The blood gas analyzers market can be expected to experience substantial growth due to the following factors, for example, growing incidences of chronic diseases, development of technologies, and point-of-care testing. In light of understanding the need for speed in performing blood analysis for use in treatment in hospital and clinics and diagnostic centers, the use of these devices is increasing. North America, Europe and Asia are most likely to dominate the future demand of telehealth supported by strong and developing healthcare facilities and continuous funding on medical products. But the forces like high cost and strict regulatory conduct may hamper the market’s growth. Due to the development of new manufacturing technology and devices that are transportable, easy to use and friendly, the home care and decentralized testing opportunities will probably grow. In conclusion, the blood gas analyzers market seems to have a good and evolving investment potential for both the old and the new key industry stakeholders who strive to optimize the diagnostic performance of blood analyzers for the betterment of patients’ health.